NADPH oxidase 1/4 dual inhibition impairs transforming growth factor-beta protumorigenic effects in cholangiocarcinoma cancer-associated fibroblasts.
Amengual J, Gonzalez-Sanchez E, Yáñez-Bartolome M, Sererols-Viñas L, Ravichandra A, Guiton C, Fuste NP, Alay A, Hijazo-Pechero S, Martín-Mur B, Gut M, Esteve-Codina A, Cantos-Cortes A, Espinosa-Sotelo R, Ramos E, Serrano T, Calvo M, Laquente B, Ferrer J, Pons G, Mendez-Lucas A, Dooley S, Ilyas SI, Vallette M, Aoudjehane L, Lequoy M, Fouassier L, Coulouarn C, Affò S, Scheiter A, Calvisi DF, Tian TV, Fabregat I, Vaquero J.
Amengual J, et al. Among authors: scheiter a.
Signal Transduct Target Ther. 2025 Aug 18;10(1):257. doi: 10.1038/s41392-025-02347-z.
Signal Transduct Target Ther. 2025.
PMID: 40820091
Free PMC article.